Why it matters: “The letter we signed this week reflects a reality that the pharmaceutical industry has observed for years: Europe is losing ground in the race for innovation,” a spokesperson from Sanofi told European Biotechnology.

Why it matters: Kasvu aims to reproduce the neuroplasticity benefits associated with psychedelics without their hallucinogenic effects. The goal is a rapid-acting, long-lasting antidepressant suitable for use at home, although that promise remains untested in humans.

Generative AI is moving into an unexpected domain: plant biology. German agtech startup Hortiya, founded in Duisburg in …

Foto: Fundecitrus O bacteriófago P27 reduziu em 60% a formação de lesões de cancro cítrico em laranjeiras mantidas …

The Philippines is tightening the link between climate intelligence and rice production, as the Philippine Rice Research…

O Brasil reúne 20 projetos de carbono agrícola e manejo do solo desenvolvidos com a metodologia VM0042, da Verra. O volu…

Brazilian farmers are heading into the 2026/27 planting season facing higher phosphate fertiliser costs as constrained s…

Previsão de acumulados de chuva de segunda-feira (28/9) até o fim de quarta-feira (30/9), conforme o modelo numérico de …

Biographica and Hudson River have announced a partnership, enabling breeding companies to take their trait ambitions all…